TABLE 2.
Treatment1 |
P-value |
||||
Phyla | CON | PHY | AY | SEM | Additive |
Actinobacteria | 11.3 | 10.0 | 7.1 | 1.24 | 0.62 |
Bacteroidetes | 1.73 | 1.95 | 0.80 | 0.353 | 0.12 |
Chloroflexi | 0.006a | 0.049b | 0.021a | 0.0127 | 0.02 |
Elusimicrobia | 0.040 | 0.032 | 0.022 | 0.0051 | 0.65 |
Euryarchaeota | 0.167 | 0.232 | 0.145 | 0.0259 | 0.38 |
Firmicutes | 50.1 | 45.1 | 50.2 | 1.66 | 0.39 |
GN02 | 0.002a | 0.031b | 0.005a | 0.0090 | 0.02 |
Planctomycetes | 0.014 | 0.034 | 0.008 | 0.0078 | 0.08 |
Proteobacteria | 35.5 | 41.1 | 40.5 | 1.77 | 0.48 |
Spirochaetes | 0.008 | 0.012 | 0.002 | 0.0030 | 0.57 |
Synergistetes | 0.64 | 0.92 | 0.68 | 0.086 | 0.30 |
Tenericutes | 0.09 | 0.08 | 0.29 | 0.067 | 0.10 |
TM7 | 0.22 | 0.22 | 0.15 | 0.023 | 0.57 |
Verrucomicrobia | 0.017 | 0.015 | 0.001 | 0.0051 | 0.54 |
WPS2 | 0.000 | 0.000 | 0.006 | 0.0019 | 0.39 |
SEM, standard error of the mean. P-value additive is based on the fixed effects ANOVA model using the Tukey–Kramer method. 1Treatment is the additive that was added to SARA diets; CON: control, no supplementation; PHY: phytogenic product; AY: autolyzed yeast. a,bDiffering superscripts in the same row indicate significant variation in comparison to the control group based on Dunnett-Hsu analysis.